Is Uber Stock a Buy on the Dip?
Shares of Uber Technologies (NYSE:UBER) have been fading fast in…
Buy
61
MNDR Quote, Financials, Valuation and Earnings
Last price:
$0.31
Seasonality move
:
--
Day range:
$0.30 - $0.33
52-week range:
$0.23 - $29.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.77x
P/B ratio:
2.61x
Volume:
981.1K
Avg. volume:
1.4M
1-year change:
--
Market cap:
$10.8M
Revenue:
$14M
EPS (TTM):
-$0.45
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
MNDR
Mobile-health Network Solutions
|
-- | -- | -- | -- | -- |
|
EUDA
EUDA Health Holdings
|
$2.3M | -$0.02 | 1702.91% | -92.93% | -- |
|
GDTC
CytoMed Therapeutics
|
$130K | -$0.04 | -- | -- | -- |
|
HAWPF
Haw Par
|
-- | -- | -- | -- | -- |
|
RAFLF
Raffles Medical Group
|
-- | -- | -- | -- | -- |
|
WVE
WAVE Life Sciences
|
$13.1M | -$0.30 | -11.91% | -61.85% | $22.30 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
MNDR
Mobile-health Network Solutions
|
$0.31 | -- | $10.8M | -- | $0.00 | 0% | 0.77x |
|
EUDA
EUDA Health Holdings
|
$4.50 | -- | $167.2M | -- | $0.00 | 0% | 64.70x |
|
GDTC
CytoMed Therapeutics
|
$2.80 | -- | $32.3M | -- | $0.00 | 0% | -- |
|
HAWPF
Haw Par
|
$8.35 | -- | $1.8B | 10.66x | $0.15 | 3.6% | 10.45x |
|
RAFLF
Raffles Medical Group
|
$0.67 | -- | $1.2B | 27.83x | $0.02 | 2.66% | 2.41x |
|
WVE
WAVE Life Sciences
|
$13.48 | $22.30 | $2.1B | -- | $0.00 | 0% | 31.57x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
MNDR
Mobile-health Network Solutions
|
-- | 0.000 | -- | 2.20x |
|
EUDA
EUDA Health Holdings
|
-69.68% | 1.387 | 2.25% | 0.07x |
|
GDTC
CytoMed Therapeutics
|
-- | -2.052 | -- | -- |
|
HAWPF
Haw Par
|
0.97% | -0.006 | 1.68% | 27.90x |
|
RAFLF
Raffles Medical Group
|
6.41% | -0.011 | 3.7% | 1.17x |
|
WVE
WAVE Life Sciences
|
-- | -0.257 | -- | 1.82x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
MNDR
Mobile-health Network Solutions
|
-- | -- | -1223.46% | -1223.46% | -- | -- |
|
EUDA
EUDA Health Holdings
|
-- | -- | -- | -- | -- | -- |
|
GDTC
CytoMed Therapeutics
|
-- | -- | -- | -- | -- | -- |
|
HAWPF
Haw Par
|
-- | -- | 6.56% | 6.62% | -- | -- |
|
RAFLF
Raffles Medical Group
|
-- | -- | 5.51% | 5.89% | -- | -- |
|
WVE
WAVE Life Sciences
|
-- | -$63.9M | -437.99% | -437.99% | 832.66% | -$46.9M |
Mobile-health Network Solutions vs. Competitors
-
Which has Higher Returns MNDR or EUDA?
EUDA Health Holdings has a net margin of -- compared to Mobile-health Network Solutions's net margin of --. Mobile-health Network Solutions's return on equity of -1223.46% beat EUDA Health Holdings's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MNDRMobile-health Network Solutions-- -- $4.1M EUDAEUDA Health Holdings-- -- -$3.5M -
What do Analysts Say About MNDR or EUDA?
Mobile-health Network Solutions has a consensus price target of --, signalling upside risk potential of 2452.65%. On the other hand EUDA Health Holdings has an analysts' consensus of -- which suggests that it could grow by 33.33%. Given that Mobile-health Network Solutions has higher upside potential than EUDA Health Holdings, analysts believe Mobile-health Network Solutions is more attractive than EUDA Health Holdings.
Company Buy Ratings Hold Ratings Sell Ratings MNDRMobile-health Network Solutions0 0 0 EUDAEUDA Health Holdings0 0 0 -
Is MNDR or EUDA More Risky?
Mobile-health Network Solutions has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison EUDA Health Holdings has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MNDR or EUDA?
Mobile-health Network Solutions has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. EUDA Health Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mobile-health Network Solutions pays -- of its earnings as a dividend. EUDA Health Holdings pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MNDR or EUDA?
Mobile-health Network Solutions quarterly revenues are --, which are smaller than EUDA Health Holdings quarterly revenues of --. Mobile-health Network Solutions's net income of -- is lower than EUDA Health Holdings's net income of --. Notably, Mobile-health Network Solutions's price-to-earnings ratio is -- while EUDA Health Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mobile-health Network Solutions is 0.77x versus 64.70x for EUDA Health Holdings. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MNDRMobile-health Network Solutions0.77x -- -- -- EUDAEUDA Health Holdings64.70x -- -- --
-
Which has Higher Returns MNDR or GDTC?
CytoMed Therapeutics has a net margin of -- compared to Mobile-health Network Solutions's net margin of --. Mobile-health Network Solutions's return on equity of -1223.46% beat CytoMed Therapeutics's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MNDRMobile-health Network Solutions-- -- $4.1M GDTCCytoMed Therapeutics-- -- -- -
What do Analysts Say About MNDR or GDTC?
Mobile-health Network Solutions has a consensus price target of --, signalling upside risk potential of 2452.65%. On the other hand CytoMed Therapeutics has an analysts' consensus of -- which suggests that it could grow by 78.77%. Given that Mobile-health Network Solutions has higher upside potential than CytoMed Therapeutics, analysts believe Mobile-health Network Solutions is more attractive than CytoMed Therapeutics.
Company Buy Ratings Hold Ratings Sell Ratings MNDRMobile-health Network Solutions0 0 0 GDTCCytoMed Therapeutics0 0 0 -
Is MNDR or GDTC More Risky?
Mobile-health Network Solutions has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison CytoMed Therapeutics has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MNDR or GDTC?
Mobile-health Network Solutions has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CytoMed Therapeutics offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mobile-health Network Solutions pays -- of its earnings as a dividend. CytoMed Therapeutics pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MNDR or GDTC?
Mobile-health Network Solutions quarterly revenues are --, which are smaller than CytoMed Therapeutics quarterly revenues of --. Mobile-health Network Solutions's net income of -- is lower than CytoMed Therapeutics's net income of --. Notably, Mobile-health Network Solutions's price-to-earnings ratio is -- while CytoMed Therapeutics's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mobile-health Network Solutions is 0.77x versus -- for CytoMed Therapeutics. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MNDRMobile-health Network Solutions0.77x -- -- -- GDTCCytoMed Therapeutics-- -- -- --
-
Which has Higher Returns MNDR or HAWPF?
Haw Par has a net margin of -- compared to Mobile-health Network Solutions's net margin of --. Mobile-health Network Solutions's return on equity of -1223.46% beat Haw Par's return on equity of 6.62%.
Company Gross Margin Earnings Per Share Invested Capital MNDRMobile-health Network Solutions-- -- $4.1M HAWPFHaw Par-- -- $2.8B -
What do Analysts Say About MNDR or HAWPF?
Mobile-health Network Solutions has a consensus price target of --, signalling upside risk potential of 2452.65%. On the other hand Haw Par has an analysts' consensus of -- which suggests that it could fall by --. Given that Mobile-health Network Solutions has higher upside potential than Haw Par, analysts believe Mobile-health Network Solutions is more attractive than Haw Par.
Company Buy Ratings Hold Ratings Sell Ratings MNDRMobile-health Network Solutions0 0 0 HAWPFHaw Par0 0 0 -
Is MNDR or HAWPF More Risky?
Mobile-health Network Solutions has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Haw Par has a beta of 0.110, suggesting its less volatile than the S&P 500 by 88.956%.
-
Which is a Better Dividend Stock MNDR or HAWPF?
Mobile-health Network Solutions has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Haw Par offers a yield of 3.6% to investors and pays a quarterly dividend of $0.15 per share. Mobile-health Network Solutions pays -- of its earnings as a dividend. Haw Par pays out 35.78% of its earnings as a dividend. Haw Par's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios MNDR or HAWPF?
Mobile-health Network Solutions quarterly revenues are --, which are smaller than Haw Par quarterly revenues of --. Mobile-health Network Solutions's net income of -- is lower than Haw Par's net income of --. Notably, Mobile-health Network Solutions's price-to-earnings ratio is -- while Haw Par's PE ratio is 10.66x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mobile-health Network Solutions is 0.77x versus 10.45x for Haw Par. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MNDRMobile-health Network Solutions0.77x -- -- -- HAWPFHaw Par10.45x 10.66x -- --
-
Which has Higher Returns MNDR or RAFLF?
Raffles Medical Group has a net margin of -- compared to Mobile-health Network Solutions's net margin of --. Mobile-health Network Solutions's return on equity of -1223.46% beat Raffles Medical Group's return on equity of 5.89%.
Company Gross Margin Earnings Per Share Invested Capital MNDRMobile-health Network Solutions-- -- $4.1M RAFLFRaffles Medical Group-- -- $811.2M -
What do Analysts Say About MNDR or RAFLF?
Mobile-health Network Solutions has a consensus price target of --, signalling upside risk potential of 2452.65%. On the other hand Raffles Medical Group has an analysts' consensus of -- which suggests that it could fall by --. Given that Mobile-health Network Solutions has higher upside potential than Raffles Medical Group, analysts believe Mobile-health Network Solutions is more attractive than Raffles Medical Group.
Company Buy Ratings Hold Ratings Sell Ratings MNDRMobile-health Network Solutions0 0 0 RAFLFRaffles Medical Group0 0 0 -
Is MNDR or RAFLF More Risky?
Mobile-health Network Solutions has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Raffles Medical Group has a beta of 0.095, suggesting its less volatile than the S&P 500 by 90.471%.
-
Which is a Better Dividend Stock MNDR or RAFLF?
Mobile-health Network Solutions has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Raffles Medical Group offers a yield of 2.66% to investors and pays a quarterly dividend of $0.02 per share. Mobile-health Network Solutions pays -- of its earnings as a dividend. Raffles Medical Group pays out 78.41% of its earnings as a dividend. Raffles Medical Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios MNDR or RAFLF?
Mobile-health Network Solutions quarterly revenues are --, which are smaller than Raffles Medical Group quarterly revenues of --. Mobile-health Network Solutions's net income of -- is lower than Raffles Medical Group's net income of --. Notably, Mobile-health Network Solutions's price-to-earnings ratio is -- while Raffles Medical Group's PE ratio is 27.83x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mobile-health Network Solutions is 0.77x versus 2.41x for Raffles Medical Group. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MNDRMobile-health Network Solutions0.77x -- -- -- RAFLFRaffles Medical Group2.41x 27.83x -- --
-
Which has Higher Returns MNDR or WVE?
WAVE Life Sciences has a net margin of -- compared to Mobile-health Network Solutions's net margin of -167.19%. Mobile-health Network Solutions's return on equity of -1223.46% beat WAVE Life Sciences's return on equity of -437.99%.
Company Gross Margin Earnings Per Share Invested Capital MNDRMobile-health Network Solutions-- -- $4.1M WVEWAVE Life Sciences-- -$0.47 $141.6M -
What do Analysts Say About MNDR or WVE?
Mobile-health Network Solutions has a consensus price target of --, signalling upside risk potential of 2452.65%. On the other hand WAVE Life Sciences has an analysts' consensus of $22.30 which suggests that it could grow by 65.43%. Given that Mobile-health Network Solutions has higher upside potential than WAVE Life Sciences, analysts believe Mobile-health Network Solutions is more attractive than WAVE Life Sciences.
Company Buy Ratings Hold Ratings Sell Ratings MNDRMobile-health Network Solutions0 0 0 WVEWAVE Life Sciences7 1 0 -
Is MNDR or WVE More Risky?
Mobile-health Network Solutions has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison WAVE Life Sciences has a beta of -1.210, suggesting its less volatile than the S&P 500 by 220.988%.
-
Which is a Better Dividend Stock MNDR or WVE?
Mobile-health Network Solutions has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. WAVE Life Sciences offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mobile-health Network Solutions pays -- of its earnings as a dividend. WAVE Life Sciences pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MNDR or WVE?
Mobile-health Network Solutions quarterly revenues are --, which are smaller than WAVE Life Sciences quarterly revenues of -$7.7M. Mobile-health Network Solutions's net income of -- is lower than WAVE Life Sciences's net income of -$61.8M. Notably, Mobile-health Network Solutions's price-to-earnings ratio is -- while WAVE Life Sciences's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mobile-health Network Solutions is 0.77x versus 31.57x for WAVE Life Sciences. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MNDRMobile-health Network Solutions0.77x -- -- -- WVEWAVE Life Sciences31.57x -- -$7.7M -$61.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is AMD Stock an All-Time Buy?
Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…
How High Will Airbnb Stock Go?
Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
54
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Sell
50
LMND alert for Dec 28
Lemonade [LMND] is down 10.69% over the past day.
Buy
60
TSLL alert for Dec 28
Direxion Daily TSLA Bull 2X Shares [TSLL] is down 9.92% over the past day.
Buy
71
SMLR alert for Dec 28
Semler Scientific [SMLR] is down 9.65% over the past day.
